We are very excited to share we have 2 new roles coming up at Peter Mac to join the dynamic radiopharmaceutical sciences research team. One role is focused on the biological evaluation of new ...

Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient ...

Based on my experiences and observations, let's explore ten new developments shaping the radiopharmaceutical industry in remarkable new ways. The industry is on a strong growth trajectory ...

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in Oppenheimer’s 35 th Annual Healthcare Life Sciences Conference. Dr. Andrew ...

Radiopharmaceutical manufacturing will be offered as a hybrid format through the Indianapolis campus and will reward a master ...

As revenues rose for Novartis’ radiopharmaceutical blockbuster Pluvicto, competitors are packing their pipelines with radiopharmaceuticals through acquisitions and licencing deals, hoping to ...

2024 saw massive interest in the radiopharmaceutical space, full of large-scale deal-making, as isotope producers struggle to meet inflated demand. Credit: Trairut Noppakaew/ Shutterstock A ...

A special session of the 'International Conference on Opportunities for Women in Nuclear Science and Emerging Technologies' was held here yesterday, bringing together global and national leaders to ...

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an ...